Crushing injury of forearm

ST19_CRUSHI_INJURY_FOREA

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — S57 Cause of death: ICD-10 — S57 2 out of 7 registries used, show all original rules.	55
4. Check minimum number of events None	55
5. Include endpoints None	55
6. Filter based on genotype QC (FinnGen only)	54

Control definitions (FinnGen only)

Control exclude: ST19_INJURI_ELBOW_FOREA

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: S5
Name in latin: Conquassatio antebrachii

NAME	ST19_CRUSHI_INJURY_FOREA
CONTROL_EXCLUDE	ST19_INJURI_ELBOW_FOREA
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	S57
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	S57
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Crushing injury of forearm based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	54	27	27
Unadjusted period prevalence (%)	0.01	0.01	0.01
Median age at first event (years)	47.80	49.53	46.07

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
55: Matched controls
550

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

S57.0

ICD-10 Finland

Crushing injury of elbow

+∞

33.9

S57.8

ICD-10 Finland

Crushing injury of other parts of forearm

+∞

21.2

ZZA00

NOMESCO Finland

Split skin graft

150.2

11.9

X59

ICD-10 Finland

Exposure to unspecified factor

7.1

11.4

QCB05

NOMESCO Finland

Revision of wound of skin of upper limb

+∞

10.8

S52.0

ICD-10 Finland

Fracture of upper end of ulna

119.8

9.7

S52.5

ICD-10 Finland

Fracture of lower end of radius

30.0

9.4

X58

ICD-10 Finland

Exposure to other specified factors

6.3

9.0

NC2AA

NOMESCO Finland

Forearm X-ray examination

+∞

8.5

NCJ62

NOMESCO Finland

Internal fixation of fracture of forearm using plate

+∞

8.5

NCJ64

NOMESCO Finland

Other internal fixation of fracture of forearm

+∞

7.4

S57.9

ICD-10 Finland

Crushing injury of forearm, part unspecified

+∞

7.4

NCU20

NOMESCO Finland

Removal of internal fixation device from elbow or forearm

+∞

7.4

WX203

NOMESCO Finland

Infraclavicular plexus blockade

45.8

7.0

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

45.8

7.0

QCE35

NOMESCO Finland

Repair of skin defect in upper limb after surgery or injury

+∞

6.4

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3019309) Folate [Moles/volume] in Red Blood Cells

3.90

4.83

1.8

1.6

1170.64

1188.30

nmol/l

0.03

(3044640) Blood type and Crossmatch panel - Blood

133

3.25

4.41

2.7

2.0

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

149

3.00

3.88

3.6

2.7

—

(3002256) Pathology report gross observation

4.28

3.72

1.0

1.2

—

(3022217) INR in Platelet poor plasma by Coagulation assay

182

2.81

3.44

19.8

11.9

1.32

1.26

inr

0.10

(3000850) Epithelial cells [#/volume] in Urine

100

2.78

3.11

2.3

2.0

7.94

4.11

e6/l

0.35

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

7.31

2.94

2.8

2.9

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

5.55

2.83

1.0

1.7

—

(36304419) Bacteria [Presence] in Urine

122

2.52

2.69

3.0

2.4

—

(3026782) Osmolality of Urine

2.63

2.67

2.9

2.7

629.84

546.35

mosm/kgh2o

1.06

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

2.72

2.58

2.2

0.59

0.97

e6/l

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

3.18

2.45

3.2

2.9

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

2.70

2.44

2.3

2.4

0.57

3.14

e6/l

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

5.03

2.34

1.7

1.5

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2.43

2.31

2.6

2.1

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

3.72

2.28

2.6

3.2

4.94

4.96

kpa

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

186

2.18

2.09

10.5

6.9

1.22

mmol/l

0.02

155

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

207

2.14

1.99

2.8

2.3

—

(3013512) EKG study

121

2.19

1.95

4.0

3.4

—

(3022948) Iron [Moles/volume] in Serum or Plasma

2.48

1.90

2.9

2.2

13.12

14.37

umol/l

0.22

(3028626) Oxygen [Partial pressure] in Capillary blood

4.11

1.75

1.4

2.2

8.04

8.45

kpa

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

4.11

1.75

3.4

4.2

24.18

24.57

mmol/l

—

(3018418) pH of Serum or Plasma

111

2.09

1.67

4.1

3.7

7.43

7.40

—

(3003694) ABO and Rh group [Type] in Blood

136

2.03

1.67

1.4

1.5

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

2.93

1.64

1.6

1.9

0.05

0.04

e6/l

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

157

1.94

1.53

2.4

1.9

105.25

91.73

pmol/l

0.83

(3037467) Urinalysis macro (dipstick) panel - Urine

291

1.99

1.51

6.2

4.4

—

(3007853) Bacteria identified in Skin by Aerobe culture

2.34

1.50

1.5

1.7

—

(3026008) Bacteria identified in Urine by Culture

124

1.96

1.48

2.8

3.3

—

(3022313) Gas panel - Capillary blood

3.33

1.47

3.0

3.6

—

(3023368) Bacteria identified in Blood by Culture

2.08

1.45

6.2

4.9

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2.80

1.41

4.0

3.7

27.88

24.83

mmol/l

—

(3000330) Specific gravity of Urine by Test strip

2.80

1.41

4.0

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

157

1.80

1.24

3.5

12.21

34.54

ng/l

0.91

101

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

106

1.87

1.21

1.4

1.8

1.51

1.42

mmol/l

0.11

(3013650) Neutrophils [#/volume] in Blood by Automated count

252

1.77

1.21

10.4

9.6

3.77

4.02

e9/l

0.41

224

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

2.17

1.18

4.1

4.9

463.13

257.35

u/l

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

433

2.20

1.10

19.4

11.3

87.81

85.93

ml/min/173m2

0.22

346

(3025159) Blasts/100 leukocytes in Blood

2.14

1.04

2.1

6.9

—

0.11

—

(4035726) Immunohistochemistry procedure

2.02

0.98

1.1

1.5

—

(40768804) Tissue Pathology biopsy report

148

1.68

0.98

2.6

1.8

—

(3013115) Eosinophils [#/volume] in Blood

225

1.61

0.92

8.4

6.3

0.20

0.18

e9/l

0.36

197

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

2.05

0.87

2.0

2.3

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1.98

0.84

2.5

1.7

—

(40768797) Stomach Pathology biopsy report

1.76

0.78

1.3

1.2

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

2.29

0.78

23.6

6.9

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

1.96

0.77

19.0

6.1

1.50

1.47

mmol/l

—

(40761536) Microorganisms panel - Urine sediment

1.91

0.76

2.3

3.6

—

(3014007) Fractional oxyhemoglobin in Arterial blood

2.10

0.75

28.6

8.7

93.20

93.74

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1.86

0.74

2.7

1.8

—

(3019198) Lymphocytes [#/volume] in Blood

224

1.51

0.73

8.6

6.0

2.15

1.84

e9/l

1.67

198

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

1.93

0.70

28.6

8.1

0.70

0.65

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

1.93

0.70

28.6

8.1

2.30

1.56

—

(3015736) pH of Urine

178

1.50

0.69

3.3

3.5

—

5.82

—

(3001604) Monocytes [#/volume] in Blood

219

1.46

0.63

8.7

6.1

0.61

0.57

e9/l

0.70

191

(3006315) Basophils [#/volume] in Blood

220

1.45

0.61

8.8

6.0

0.05

0.04

e9/l

1.55

191

(3019225) pH of Specimen

1.86

0.61

4.2

3.8

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1.48

0.55

1.1

1.7

—

(40760892) CBC W Ordered Manual Differential panel - Blood

205

1.40

0.53

9.8

7.1

—

(3000492) Spirometry study

1.46

0.47

1.1

1.5

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1.46

0.47

2.4

2.0

—

(3042936) Bacteria identified in Isolate by Culture

1.53

0.46

2.0

1.7

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1.67

0.44

1.2

1.7

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1.67

0.44

3.0

1.6

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1.67

0.44

3.0

1.6

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

0.00

0.42

0.0

1.3

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.42

0.0

1.6

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

0.00

0.41

0.0

1.1

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

0.00

0.41

0.0

1.6

—

(3035350) Ketones [Presence] in Urine by Test strip

224

1.30

0.37

3.5

3.7

0.00

0.02

estimate

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

111

1.35

0.34

1.6

1.9

—

(3003396) Base excess in Arterial blood by calculation

1.34

0.34

25.0

7.5

0.43

0.42

mmol/l

—

(40758558) Short blood count panel - Blood

102

1.36

0.34

8.9

6.8

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

1.43

0.33

21.4

6.0

107.00

103.75

mmol/l

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

131

1.31

0.32

5.4

3.9

12.43

21.03

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1.32

0.29

1.4

1.6

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1.32

0.27

1.2

1.7

—

(21494755) Public health laboratory ask at order entry panel

1.28

0.27

1.0

1.5

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

324

1.22

0.23

2.9

3.2

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.4

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

0.00

0.21

0.0

1.9

—

138.52

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.4

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

0.00

0.21

0.0

1.6

—

20.50

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

0.00

0.21

0.0

1.3

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

0.00

0.21

0.0

1.0

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.4

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.9

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

0.00

0.21

0.0

2.1

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

0.00

0.21

0.0

2.1

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

0.00

0.21

0.0

2.1

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

0.00

0.21

0.0

2.1

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

0.00

0.21

0.0

2.1

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.9

—

(3024928) Oxygen saturation in Venous blood

0.00

0.21

0.0

3.0

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.7

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1.31

0.21

3.8

6.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1.28

0.21

1.7

2.1

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

0.00

0.21

0.0

2.1

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.5

—

10.15

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

0.00

0.20

0.0

1.6

—

(40768443) Skin Pathology biopsy report

0.00

0.20

0.0

1.3

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

1.26

0.19

2.8

3.8

—

(40761511) CBC panel - Blood by Automated count

493

0.79

0.19

19.4

10.7

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

0.73

0.18

3.0

1.4

—

(3012544) pH of Venous blood

1.18

0.10

3.0

3.5

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1.15

0.10

1.2

1.7

—

(3002032) Base excess in Venous blood by calculation

1.10

0.10

2.8

3.2

2.78

2.41

mmol/l

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1.17

0.10

1.8

1.7

—

(3022145) Colonoscopy Study observation

1.15

0.09

1.0

1.4

—

(3000494) Fungus identified in Specimen by Culture

1.06

0.09

1.3

1.4

—

(3019832) Treponema pallidum Ab [Presence] in Serum

0.79

0.09

1.2

1.6

—

(3041096) Erythrocytes [Presence] in Urine by Automated

137

1.13

0.08

4.0

3.3

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1.05

0.08

2.8

2.0

—

(3002385) Erythrocyte distribution width [Ratio]

409

1.11

0.06

27.6

13.6

14.36

14.79

0.20

400

(3013707) Erythrocyte sedimentation rate by Westergren method

332

1.06

0.02

5.1

3.9

12.07

10.17

mm/h

0.51

307

(3044889) 12 lead EKG panel

304

1.05

0.00

4.3

3.5

—

(1761868) Lipid panel - Serum or Plasma

197

1.02

0.00

3.5

2.4

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

182

0.98

0.00

3.6

3.7

—

(3007164) IgA [Mass/volume] in Serum or Plasma

108

1.02

0.00

1.3

1.4

3.86

2.44

g/l

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

338

1.02

0.00

4.3

2.9

40.30

43.21

u/l

0.18

326

(3024666) Lithium [Moles/volume] in Serum or Plasma

0.00

0.0

7.8

—

0.59

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.3

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

0.00

0.0

1.0

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

0.00

0.0

11.0

—

12.05

—

(3011648) Oxygen content in Venous blood

0.00

0.0

3.0

—

13.37

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.3

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.2

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

0.00

0.0

1.0

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.3

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.3

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

0.00

0.0

1.3

—

101.33

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

0.00

0.0

1.0

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

0.00

0.0

2.0

—

357.33

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

0.00

0.0

1.0

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

0.00

0.0

1.7

—

2.08

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

0.00

0.0

1.0

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.3

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

0.00

-0.00

0.0

2.3

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

0.00

-0.00

0.0

1.7

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.4

—

(3019230) Fractional oxyhemoglobin in Venous blood

0.00

-0.00

0.0

2.6

—

68.69

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

0.00

-0.00

0.0

6.0

—

4.53

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

0.00

-0.00

0.0

1.3

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

0.00

-0.00

0.0

1.8

—

8.62

—

(3002523) Influenza virus A Ag [Presence] in Specimen

0.00

-0.00

0.0

1.4

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

2.8

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

0.00

-0.00

0.0

1.8

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

0.93

-0.00

2.9

2.0

—

(3026389) Candida sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.3

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.9

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.1

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.9

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

0.00

-0.00

0.0

1.7

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

2.8

—

(3004616) Nuclear Ab [Presence] in Serum

0.00

-0.00

0.0

1.2

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.2

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

0.00

-0.00

0.0

1.1

—

(40760888) Immunoglobulin light chains.free panel - Serum

0.00

-0.00

0.0

1.2

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

2.2

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

0.00

-0.00

0.0

2.3

—

(3042631) Mycobacterium sp identified in Specimen

0.00

-0.00

0.0

6.0

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

0.00

-0.00

0.0

1.0

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

0.00

-0.00

0.0

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.9

—

(21494815) CD4 cells/100 lymphocytes in Specimen

0.00

-0.00

0.0

1.8

—

32.70

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

0.00

-0.00

0.0

1.5

—

(40768795) Lymph node Pathology biopsy report

0.00

-0.00

0.0

1.0

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

2.4

—

(3003740) Influenza virus B Ag [Presence] in Specimen

0.00

-0.00

0.0

1.4

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

0.00

-0.00

0.0

7.9

—

58.00

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

2.4

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

1.7

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

0.00

-0.00

0.0

1.4

—

6.36

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

2.2

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: ST19_CRUSHI_INJURY_FOREA – Crushing injury of forearm

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Crushing injury of forearm

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Crushing injury of forearm (ST19_CRUSHI_INJURY_FOREA)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints